Grey Matters Health Inc. is a listed company. Its insiders report their share dealings to SEDI. 8 insiders have disclosed 122 filings since 18 October 2025.
Every open-market trade in the period is a purchase: 5 purchases worth €8,995, from 2 insiders, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €2,243, bought by Moreau, Christopher and made public on 8 October 2026 (0.089% of market cap). The buyers include 2 senior executives.
Across the 2,121 companies tracked on its exchange, the median is 11 filings; at 122 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 5 purchases and no sales.
The clock since the last published purchase (8 October 2026) now reads 9 days.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended August 2025 · cache
25 of 122 declarations
Grey Matters Health Inc. is a company focused on the healthcare sector, providing innovative solutions to enhance patient care. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Grey Matters Health drew a two-insider buying cluster in late June. Here is how the filings read against micro-cap biote...
Grey Matters Health drew a June 29 insider buy from CEO Christopher J. Moreau as healthcare strength and a fresh financi...